Project Details
Description
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets, in Androgenetic Alopecia in Males with a Comparator Arm
Status | Finished |
---|---|
Effective start/end date | 3/1/16 → 3/30/21 |
Funding
- ALLERGAN, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.